Answers are grounded in this paper and cite their sources.
Calcium antagonists exert cardioprotective effects in coronary disease through a combination of reduced myocardial oxygen demand and improved oxygen supply via vasodilation.
The application of Ca antagonists as antianginal, antiarrhythmic, antihypertensive, or cardioprotective drugs makes use of the different manifestations of the same fundamental inhibitory action on transmembrane Ca conductivity. The beneficial influence of Ca antagonists in coronary disease is probably complex because at least three therapeutically important factors seem to work together: (1) direct reduction of myocardial energy expenditure and, therefore, oxygen demand: (2) indirect decrease in cardiac oxygen requirement by facilitation of heart work at a reduced level of arterial blood pressure: and (3) improvement of myocardial oxygen supply due to vasodilator or spasmolytic effects particularly on extramural coronary vessels (stem arteries, collaterals, anastomoses).
No takes yet. Share an insight, caveat, or question.
Fleckenstein et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: